Stay updated on Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial
Sign up to get notified when there's something new on the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page.

Latest updates to the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2, indicating a minor metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoChange DetectedMinor administrative update to the page: added Revision: v3.4.1 and removed Revision: v3.4.0; this does not modify study content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check32 days agoChange DetectedNew UI elements include a glossary display option and updated footer/version labels: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; the previous labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check39 days agoChange DetectedRevision: v3.3.4 added and v3.3.3 removed on the page. This is a minor metadata update and does not change the study information.SummaryDifference0.1%

- Check67 days agoChange DetectedFooter revision updated to Revision: v3.3.3, and HHS Vulnerability Disclosure and Revision: v3.3.2 links were removed.SummaryDifference0.1%

- Check89 days agoChange DetectedMinor revision update from v3.3.1 to v3.3.2; no impact on study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page.